GL1X · GenesisL1 explorer

MolNFT v1 · #116022 · protein

Kinase domain of csrc in complex with RL235

5D11 · Proto-oncogene tyrosine-protein kinase src: “Kinase domain of csrc in complex with RL235”. X-ray diffraction, 1 ligand (56G), 3 pockets (best druggability 0.71). MolNFT v1 #116022 on GenesisL1: 3D structure, binding sites and…

PDB
5D11
Type
protein
Length
509 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase src
EC
2.7.10.2
UniProt
P00523
Ligands
56G
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein25440% helix, 17% strandP00523
BProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein25541% helix, 17% strandP00523

Ligands and binding sites

  • 56G · N-[3-({4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}oxy)phenyl]prop-2-enamide · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19030.710.769856G
23650.600.7742empty
32210.570.793656G

Interfaces

1 interface between chains.

  • A–B · 364 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 5D11 · Kinase domain of cSrc in complex with RL235 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.